Kyle McKee

Kyle is the Research Engagement Manager at Horizon Health Network, with a background in research coordination and engagement. He holds a Master of Science in Neuroscience from McGill University (2018). Prior to joining Horizon Health network, Kyle served as a Research Coordinator for two prominent research groups at Dalhousie University and Nova Scotia Health – focusing on adolescent mental health, addiction, and the impacts of cannabis on brain development. Outside of research, he enjoys spending time with family, exploring new places, and listening to audiobooks.

“My goal is to help bridge the gap between research and practice by actively involving clinicians, employees, policymakers, and the public in the research process, making science more relevant and impactful – ensuring that research outcomes directly benefit the populations Horizon serves.”

Selected Publications:

McKee, K. A. et al. Short communication: Prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis. Journal of Psychiatric Research 165, 77–82 (2023).

McKee, K. A. et al. Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: a systematic review and meta-analysis of randomised controlled trials. J Psychiatr Res 140, 267–281 (2021).

Tibbo PG, McKee KA, Meyer JH, et al. Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? The Canadian Journal of Psychiatry. 2021;66(2):185-194.